SYNTHESE UND REAKTIVITAET VON DIENYLMETALL-VERBINDUNGEN. VII. CYCLOPENTADIENYLNICKEL-KOMPLEXE MIT BIS(DIPHENYLARSINO)ALKYLIDEN-LIGANDEN

DOI: 10.1016/S0022-328X(00)83804-8

Source and publish data:

Journal of Organometallic Chemistry p. C53 - C57 (1982)

Update date:2022-08-04

Topics:

Authors:

Kuhn, N.

Winter, M.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0022-328X(00)83804-8

Bis(diphenylarsino)alkylidenes (C6H5)2As(CH2)nAs(C6H5)2 (L-L, n = 1,2) react with BF4 to give the complexes BF4.I^- substitutes the anion to give the correspodning iodo complexes.

Full text of DOI:10.1016/S0022-328X(00)83804-8

Products guided by the article

Product name:[C₅H₅Ni((C₆H₅)2AsC₂H₄As(C₆H₅)2)]⁽¹⁺⁾*BF₄^(1-)=[C₅H₅Ni((C₆H₅)2AsC₂H₄As(C₆H₅)2)]BF₄

Cas No:84664-77-7

R&D Labs maybe for 84664-77-7

WUHAN RISON TRADING CO.,LTD

Contact:0086-27-83607103/83642615

Address:No.498, Jianshe Ave, Wuhan, China
Guangzhou Chemical Reagent Factory

Contact:+86-20-8435 9820 or 8435 7345

Address:Southern Guangzhou, Guangdong, China
Esuccess Material Limited

Contact:852-29282288

Address:HONGKONG
FOSHAN NANHAI ZHONGNAN PHARMACEUTICAL FACTORY

Contact:0086-0757-85609331

Address:XIAHENGTIAN INDUSTRIAL ZONE,SHAYONG VILLAGE,LISHUI TOWN
Shanghai Longjin Metallic Material Co., Ltd.

website:http://www.shlongjin.cn/

Contact:021-56517503,56502257

Address:No.16, Lane 555, Chengyin Road, Shanghai

Relevant to this article

Fluorine-directed glycosylation

Doi:10.1002/anie.201004467
(2010)
GEMINAL SYSTEMS. COMMUNICATION 20. STRUCTURE AND PROPERTIES OF AMINOMETHYLPHOSPHONIUM SALTS

Doi:10.1007/BF00950658
(1982)
5-phenyl-2-(pyrazol-4-yl)-1,3,4-thiadiazoles

Doi:10.1007/s10593-005-0201-9
(2005)
Quinoline- and 1,8-naphthyridine-3-carboxylic acids using a self-catalyzed Friedl?nder approach

Doi:10.1016/j.tetlet.2014.04.010
(2014)
A Convenient Synthesis for 3-Alkyl- and 3-Alkenylfurans, Including Perillene

Doi:10.1021/jo00155a038
(1983)
Synthesis and biological evaluation of RGD-Conjugated MEK1/2 kinase inhibitors for integrin-targeted cancer therapy

Doi:10.3390/molecules181113957
(2013)

Article Doi